Effect of Fat-Soluble Vitamins A, D, E and K on Vitamin Status and Metabolic Profile in Patients with Fat Malabsorption with and without Urolithiasis

Nutrients. 2020 Oct 12;12(10):3110. doi: 10.3390/nu12103110.

Abstract

Patients with intestinal fat malabsorption and urolithiasis are particularly at risk of acquiring fat-soluble vitamin deficiencies. The aim of the study was to evaluate the vitamin status and metabolic profile before and after the supplementation of fat-soluble vitamins A, D, E and K (ADEK) in 51 patients with fat malabsorption due to different intestinal diseases both with and without urolithiasis. Anthropometric, clinical, blood and 24-h urinary parameters and dietary intake were assessed at baseline and after ADEK supplementation for two weeks. At baseline, serum aspartate aminotransferase (AST) activity was higher in stone formers (SF; n = 10) than in non-stone formers (NSF; n = 41) but decreased significantly in SF patients after supplementation. Plasma vitamin D and E concentrations increased significantly and to a similar extent in both groups during intervention. While plasma vitamin D concentrations did not differ between the groups, vitamin E concentrations were significantly lower in the SF group than the NSF group before and after ADEK supplementation. Although vitamin D concentration increased significantly in both groups, urinary calcium excretion was not affected by ADEK supplementation. The decline in plasma AST activity in patients with urolithiasis might be attributed to the supplementation of ADEK. Patients with fat malabsorption may benefit from the supplementation of fat-soluble vitamins ADEK.

Keywords: calcium oxalate stone formation; fat-soluble vitamins; hyperoxaluria; hypocitraturia; intestinal resection; kidney stones; malabsorption; vitamin D; vitamin E; ß-carotene.

MeSH terms

  • Adult
  • Aged
  • Aspartate Aminotransferases / blood
  • Cholesterol / blood
  • Dietary Supplements
  • Female
  • Humans
  • Malabsorption Syndromes / blood*
  • Malabsorption Syndromes / complications
  • Malabsorption Syndromes / therapy
  • Male
  • Middle Aged
  • Prospective Studies
  • Triglycerides / blood
  • Urolithiasis / blood*
  • Urolithiasis / complications
  • Urolithiasis / therapy
  • Vitamin A / administration & dosage
  • Vitamin A / blood*
  • Vitamin A Deficiency / blood
  • Vitamin A Deficiency / etiology
  • Vitamin A Deficiency / therapy
  • Vitamin D / administration & dosage
  • Vitamin D / blood*
  • Vitamin D Deficiency / blood
  • Vitamin D Deficiency / etiology
  • Vitamin D Deficiency / therapy
  • Vitamin E / administration & dosage
  • Vitamin E / blood*
  • Vitamin E Deficiency / blood
  • Vitamin E Deficiency / etiology
  • Vitamin E Deficiency / therapy
  • Vitamin K / administration & dosage
  • Vitamin K / blood*
  • Vitamin K Deficiency / blood
  • Vitamin K Deficiency / etiology
  • Vitamin K Deficiency / therapy
  • Vitamins / administration & dosage
  • Vitamins / blood

Substances

  • Triglycerides
  • Vitamins
  • Vitamin A
  • Vitamin K
  • Vitamin D
  • Vitamin E
  • Cholesterol
  • Aspartate Aminotransferases